ID27205A - Komposisi-komposisi farmasi, fenilamidin tersubstitusi yang mengandung senyawa-senyawa ini dan proses pembuatannya. - Google Patents

Komposisi-komposisi farmasi, fenilamidin tersubstitusi yang mengandung senyawa-senyawa ini dan proses pembuatannya.

Info

Publication number
ID27205A
ID27205A IDW20010171A ID20010171A ID27205A ID 27205 A ID27205 A ID 27205A ID W20010171 A IDW20010171 A ID W20010171A ID 20010171 A ID20010171 A ID 20010171A ID 27205 A ID27205 A ID 27205A
Authority
ID
Indonesia
Prior art keywords
phenilamidins
substituted
compounds
making
pharmacy compositions
Prior art date
Application number
IDW20010171A
Other languages
English (en)
Inventor
Frank Dr Himmelsbach
Brian Dr Guth
Hans-Dieter Schubert
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of ID27205A publication Critical patent/ID27205A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C07C211/49Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring having at least two amino groups bound to the carbon skeleton
    • C07C211/50Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring having at least two amino groups bound to the carbon skeleton with at least two amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW20010171A 1998-07-23 1999-07-20 Komposisi-komposisi farmasi, fenilamidin tersubstitusi yang mengandung senyawa-senyawa ini dan proses pembuatannya. ID27205A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833105A DE19833105A1 (de) 1998-07-23 1998-07-23 Substituierte Phenylamidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ID27205A true ID27205A (id) 2001-03-08

Family

ID=7875009

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010171A ID27205A (id) 1998-07-23 1999-07-20 Komposisi-komposisi farmasi, fenilamidin tersubstitusi yang mengandung senyawa-senyawa ini dan proses pembuatannya.

Country Status (30)

Country Link
EP (1) EP1102746B1 (id)
JP (1) JP3629208B2 (id)
KR (1) KR20010072046A (id)
CN (1) CN1310708A (id)
AR (1) AR019462A1 (id)
AT (1) ATE240297T1 (id)
AU (1) AU5285399A (id)
BG (1) BG105159A (id)
BR (1) BR9912321A (id)
CA (1) CA2337413A1 (id)
CO (1) CO5080745A1 (id)
DE (2) DE19833105A1 (id)
DK (1) DK1102746T3 (id)
EA (1) EA200100106A1 (id)
EE (1) EE200100048A (id)
ES (1) ES2199587T3 (id)
HK (1) HK1038750A1 (id)
HU (1) HUP0103327A3 (id)
ID (1) ID27205A (id)
IL (1) IL140774A0 (id)
NO (1) NO20010354L (id)
PL (1) PL345624A1 (id)
PT (1) PT1102746E (id)
SK (1) SK1052001A3 (id)
TR (1) TR200100182T2 (id)
TW (1) TW460461B (id)
UY (1) UY25621A1 (id)
WO (1) WO2000005207A1 (id)
YU (1) YU3701A (id)
ZA (1) ZA200100363B (id)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10002510A1 (de) * 2000-01-21 2001-07-26 Boehringer Ingelheim Pharma Substituierte Phenylamidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US8399678B2 (en) * 2009-11-18 2013-03-19 Boehringer Ingelheim International Gmbh Process for the manufacture of dabigatran etexilate
EP2522662A1 (en) * 2011-05-11 2012-11-14 Medichem, S.A. Dabigatran etexilate and related substances, processes and compositions, and use of the substances as reference standards and markers
CN105330568B (zh) * 2015-11-27 2017-05-10 山东省医学科学院药物研究所 一种对氨基苯甲脒盐酸盐的制备方法
CN105732433A (zh) * 2016-04-13 2016-07-06 山东新华制药股份有限公司 达比加群酯中间体缩合物的精制方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU691361B2 (en) * 1994-12-01 1998-05-14 Toyama Chemical Co. Ltd. Novel 2,3-diketopiperazine derivative or salt thereof
DE19515500A1 (de) * 1995-04-27 1996-10-31 Thomae Gmbh Dr K Substituierte Phenylamidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
NO20010354D0 (no) 2001-01-22
EA200100106A1 (ru) 2001-08-27
HUP0103327A3 (en) 2003-11-28
CA2337413A1 (en) 2000-02-03
UY25621A1 (es) 2001-12-28
PL345624A1 (en) 2002-01-02
PT1102746E (pt) 2003-10-31
AR019462A1 (es) 2002-02-20
YU3701A (sh) 2003-01-31
AU5285399A (en) 2000-02-14
ES2199587T3 (es) 2004-02-16
TW460461B (en) 2001-10-21
CN1310708A (zh) 2001-08-29
HK1038750A1 (zh) 2002-03-28
TR200100182T2 (tr) 2001-07-23
EP1102746A1 (de) 2001-05-30
CO5080745A1 (es) 2001-09-25
EP1102746B1 (de) 2003-05-14
NO20010354L (no) 2001-01-22
DE19833105A1 (de) 2000-01-27
HUP0103327A2 (hu) 2002-01-28
DE59905568D1 (de) 2003-06-18
SK1052001A3 (en) 2001-08-06
ATE240297T1 (de) 2003-05-15
BR9912321A (pt) 2001-04-24
JP3629208B2 (ja) 2005-03-16
ZA200100363B (en) 2001-07-18
KR20010072046A (ko) 2001-07-31
JP2002521363A (ja) 2002-07-16
WO2000005207A1 (de) 2000-02-03
BG105159A (bg) 2001-07-31
IL140774A0 (en) 2002-02-10
DK1102746T3 (da) 2003-09-08
EE200100048A (et) 2002-06-17

Similar Documents

Publication Publication Date Title
ID24929A (id) Turunan 2-aril-8-oksodihidropurin, proses pembuatannya, komposisi farmasinya yang mengandungnya, dan senyawa antaranya
ID30299A (id) Turunan oksazolidinon, proses pembuatannya dan komposisi farmasi yang mengandungnya
ID25528A (id) Karboksamidotiazol tersubstitusi, pembuatannya dan komposisi farmasi yang mengandungnya
MXPA00007681A (es) Composiciones de epotilona.
ID18046A (id) Senyawa siklik campuran, pembuatan dan penngunaannya.
BR9915515B1 (pt) composiÇço curÁvel de multicomponentes.
HK1021313A1 (en) Tetrahydrolipstatin containing compositions.
ZA9810125B (en) Chemical compounds.
DE69802615D1 (de) Triaromatische Verbindungen, diese enthaltende Zusammensetzungen sowie ihre Anwendungen
ZA993364B (en) Novel 4-phenylpiperidines for the treatment of pruritic dermatoses.
HUP0102483A3 (en) Pharmaceutical compositions containing androst-5-ene-3betha,17betha-diol
ID25543A (id) Alpha-aril-n-alkinitron dan komposisi farmasi yang mengandungnya
HK1038884A1 (en) Medicinal compositions.
ID17810A (id) Turunan-turunan 2,4-tiazolidindion tersubstitusi baru, proses untuk pembuatannya dan komposisi farmasi yang mengandungnya
ID20137A (id) Turunan propanolamina, proses pembuatannya, sediaan farmasi yang mengandung senyawa ini, dan penggunannya
ID29295A (id) Senyawa pirimidinona, komposisi farmasi yang mengandung senyawa tersebut dan proses penyediaannya senyawa tersebut
ZA200005510B (en) Pharmaceutical composition.
ID22911A (id) Turunan-turunan triazol baru, proses pembuatan dan komposisi-komposisi farmasi yang mengandungnya
IS2296B (is) Aðferð til framleiðslu á vernduðu 4-amínómetýl-pýrrólidín-3-óni.
NO20010873D0 (no) Mikropartikkel-blanding
ID26506A (id) Turunan-turunan n-fenilamida dan n-piridilamida, metode pembuatannya dan komposisi-komposisi farmasi yang mengandungnya
ID27205A (id) Komposisi-komposisi farmasi, fenilamidin tersubstitusi yang mengandung senyawa-senyawa ini dan proses pembuatannya.
ID23784A (id) Proses pembuatan turunan alkoksifuranonamina, senyawa-senyawa yang diperoleh melalui proses ini, dan penggunaan senyawa-senyawa ini.
ZA9810063B (en) Process for the manufacture of an organic compound.
HK1044117A1 (en) Pharmaceutical composition.